These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 28143871)

  • 41. Pre-miRNA variants as predictors of clinical outcome in patients with squamous cell carcinomas of the nonoropharynx.
    Wang C; Sturgis EM; Chen X; Zheng H; Wei Q; Li G
    Oncotarget; 2016 May; 7(18):26444-53. PubMed ID: 27050146
    [TBL] [Abstract][Full Text] [Related]  

  • 42. microRNA-504 inhibits cancer cell proliferation via targeting CDK6 in hypopharyngeal squamous cell carcinoma.
    Kikkawa N; Kinoshita T; Nohata N; Hanazawa T; Yamamoto N; Fukumoto I; Chiyomaru T; Enokida H; Nakagawa M; Okamoto Y; Seki N
    Int J Oncol; 2014 Jun; 44(6):2085-92. PubMed ID: 24647829
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enforced expression of hsa-miR-125a-3p in breast cancer cells potentiates docetaxel sensitivity via modulation of BRCA1 signaling.
    Xu X; Lv YG; Yan CY; Yi J; Ling R
    Biochem Biophys Res Commun; 2016 Oct; 479(4):893-900. PubMed ID: 27693788
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Targeting mTOR and AREG with everolimus, sunitinib and sorafenib in HPV-positive and -negative SCC.
    Aderhold C; Faber A; Umbreit C; Birk R; Weiss C; Sommer JU; Hörmann K; Schultz JD
    Anticancer Res; 2015 Apr; 35(4):1951-9. PubMed ID: 25862847
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MiR-362-3p is downregulated by promoter methylation and independently predicts shorter OS of cervical squamous cell carcinoma.
    Song L; Liu S; Yao H; Zhang L; Li Y; Xu D; Li Q
    Biomed Pharmacother; 2019 Jul; 115():108944. PubMed ID: 31082771
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tumour-suppressive microRNA-874 contributes to cell proliferation through targeting of histone deacetylase 1 in head and neck squamous cell carcinoma.
    Nohata N; Hanazawa T; Kinoshita T; Inamine A; Kikkawa N; Itesako T; Yoshino H; Enokida H; Nakagawa M; Okamoto Y; Seki N
    Br J Cancer; 2013 Apr; 108(8):1648-58. PubMed ID: 23558898
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Alteration of microRNA profiles in squamous cell carcinoma of the head and neck cell lines by human papillomavirus.
    Wald AI; Hoskins EE; Wells SI; Ferris RL; Khan SA
    Head Neck; 2011 Apr; 33(4):504-12. PubMed ID: 20652977
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Negative Regulation of Serine Threonine Kinase 11 (STK11) through miR-100 in Head and Neck Cancer.
    Figueroa-González G; Carrillo-Hernández JF; Perez-Rodriguez I; Cantú de León D; Campos-Parra AD; Martínez-Gutiérrez AD; Coronel-Hernández J; García-Castillo V; López-Camarillo C; Peralta-Zaragoza O; Jacobo-Herrera NJ; Guardado-Estrada M; Pérez-Plasencia C
    Genes (Basel); 2020 Sep; 11(9):. PubMed ID: 32911741
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p) coordinately targeted MTDH in lung squamous cell carcinoma.
    Mataki H; Seki N; Mizuno K; Nohata N; Kamikawaji K; Kumamoto T; Koshizuka K; Goto Y; Inoue H
    Oncotarget; 2016 Nov; 7(44):72084-72098. PubMed ID: 27765924
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tumour-suppressive microRNA-29s inhibit cancer cell migration and invasion by targeting laminin-integrin signalling in head and neck squamous cell carcinoma.
    Kinoshita T; Nohata N; Hanazawa T; Kikkawa N; Yamamoto N; Yoshino H; Itesako T; Enokida H; Nakagawa M; Okamoto Y; Seki N
    Br J Cancer; 2013 Nov; 109(10):2636-45. PubMed ID: 24091622
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MicroRNA expression patterns in oral squamous cell carcinoma: hsa-mir-99b-3p and hsa-mir-100-5p as novel prognostic markers for oral cancer.
    Jakob M; Mattes LM; Küffer S; Unger K; Hess J; Bertlich M; Haubner F; Ihler F; Canis M; Weiss BG; Kitz J
    Head Neck; 2019 Oct; 41(10):3499-3515. PubMed ID: 31355988
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dual-receptor (EGFR and c-MET) inhibition by tumor-suppressive miR-1 and miR-206 in head and neck squamous cell carcinoma.
    Koshizuka K; Hanazawa T; Fukumoto I; Kikkawa N; Matsushita R; Mataki H; Mizuno K; Okamoto Y; Seki N
    J Hum Genet; 2017 Jan; 62(1):113-121. PubMed ID: 27169691
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Integrated analysis of deregulation microRNA expression in head and neck squamous cell carcinoma.
    Qi CL; Sheng JF; Huang ML; Zou Y; Wang YP; Wang F; Zeng F; Hua QQ; Chen SM
    Medicine (Baltimore); 2021 Feb; 100(6):e24618. PubMed ID: 33578572
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human papillomavirus E7 serology and association with p16 immunohistochemistry in squamous cell carcinoma of the head and neck.
    Khanal S; Joh J; Kwon AM; Zahin M; Perez CA; Dunlap NE; Silverman CL; Tennant PA; Potts KL; Kloecker GH; Bumpous JM; Ghim SJ; Jenson AB; Redman RA
    Exp Mol Pathol; 2015 Oct; 99(2):335-40. PubMed ID: 26116154
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MiR-22-3p Regulates Cell Proliferation and Inhibits Cell Apoptosis through Targeting the eIF4EBP3 Gene in Human Cervical Squamous Carcinoma Cells.
    Lv KT; Liu Z; Feng J; Zhao W; Hao T; Ding WY; Chu JP; Gao LJ
    Int J Med Sci; 2018; 15(2):142-152. PubMed ID: 29333098
    [No Abstract]   [Full Text] [Related]  

  • 56. Suppression of MicroRNA 424 Levels by Human Papillomaviruses Is Necessary for Differentiation-Dependent Genome Amplification.
    Hong S; Cheng S; Songock W; Bodily J; Laimins LA
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978708
    [TBL] [Abstract][Full Text] [Related]  

  • 57. HPV-16 E6/E7 promotes cell migration and invasion in cervical cancer via regulating cadherin switch in vitro and in vivo.
    Hu D; Zhou J; Wang F; Shi H; Li Y; Li B
    Arch Gynecol Obstet; 2015 Dec; 292(6):1345-54. PubMed ID: 26093522
    [TBL] [Abstract][Full Text] [Related]  

  • 58. mTOR inhibition prevents rapid-onset of carcinogen-induced malignancies in a novel inducible HPV-16 E6/E7 mouse model.
    Callejas-Valera JL; Iglesias-Bartolome R; Amornphimoltham P; Palacios-Garcia J; Martin D; Califano JA; Molinolo AA; Gutkind JS
    Carcinogenesis; 2016 Oct; 37(10):1014-25. PubMed ID: 27538837
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Integration of high-risk human papillomavirus into cellular cancer-related genes in head and neck cancer cell lines.
    Walline HM; Goudsmit CM; McHugh JB; Tang AL; Owen JH; Teh BT; McKean E; Glover TW; Graham MP; Prince ME; Chepeha DB; Chinn SB; Ferris RL; Gollin SM; Hoffmann TK; Bier H; Brakenhoff R; Bradford CR; Carey TE;
    Head Neck; 2017 May; 39(5):840-852. PubMed ID: 28236344
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of human papillomavirus-16 infection on CD8+ T-cell recognition of a wild-type sequence p53264-272 peptide in patients with squamous cell carcinoma of the head and neck.
    Sirianni N; Ha PK; Oelke M; Califano J; Gooding W; Westra W; Whiteside TL; Koch WM; Schneck JP; DeLeo A; Ferris RL
    Clin Cancer Res; 2004 Oct; 10(20):6929-37. PubMed ID: 15501971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.